Enhancing the solubility and potency of tetrahydrocurcumin as an anti-cancer agent using a β-cyclodextrin inclusion complex approach
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0305171 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Zhi Xuan Low und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Applied Sciences, UCSI University, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Curcumin, beta-Cyclodextrins, Solubility, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education, Malaysia, UCSI University Research Excellence & Innovation Grant, National University of Medical Sciences.
Abstract (Originalsprache)
Curcuminoids originating from turmeric roots are renowned for their diverse pharmacological applications, particularly as a natural anticancer agent. Unfortunately, harnessing the full potential of curcumin derivatives in cancer therapy has been impeded by its inherent limitations, specifically instabilities owing to poor solubility, leading to low systemic bioavailability under normal physiological circumstances. To circumvent this, a novel organic-based drug delivery system employing physically adsorbed β-cyclodextrin (βCD) as an excipient was developed in this study. This resulted in improved aqueous dispersion coupled with anticancer enhancements of tetrahydrocurcumin (THC) at a molar ratio of 2:1. Encapsulation of this agent was confirmed by physicochemical characterisation using UV–vis spectroscopy, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), and both in vitro and in vivo approaches. Through the presence of an inclusion complex, a higher aqueous dispersion (65-fold) resulting in a higher drug content and an elevated release profile was achieved. Athymic nude (Nu/Nu) mice exposed to this treatment displayed improvements in tumour regression compared to stand-alone agents, consistent with in vitro cytotoxicity assays with an SI value > 10. The inclusion complex further enhanced apoptosis, as well as anti-migration and anti-invasion rates. Mechanistically, this formulation was consistent in terms of caspase 3 activation. Furthermore, the inclusion complex exhibited reduced systemic toxicity, including reduced inflammation in vital organs as examined by hematoxylin and eosin (H&E) staining. This study also revealed a notable sequential reduction in serum levels of tumour markers, including carcinoembryonic antigen (CEA) and mouse Cytochrome P450 1A2 (CYP1A2), correlating with a significant decrease in tumour bulk volume upon treatment commencement. These compelling findings highlight the potential of this formulation to empower insoluble or poorly soluble hydrophobic agents, thus offering promising prospects for their effective utilisation in colorectal cancer (CRC) chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Faculty of Applied Sciences, UCSI University, Kuala Lumpur, Malaysia.
- Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi, Selangor, Malaysia.
- Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia.
- Department of Organic Chemistry, Faculty of Pharmaceutical Sciences, Medical University of Silesia, Katowice, Poland.
- Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan.
ORCID-Profile: Zhi Xuan Low, Michelle Yee Mun Teo, Vijayaraj Kumar Palanirajan, Beata Morak-Młodawska
Förderung
- Ministry of Higher Education, Malaysia
- UCSI University Research Excellence & Innovation Grant
- National University of Medical Sciences
Zitieren
APA
Low, Z. X., Teo, M. Y. M., Juliana Nordin, F., Palanirajan, V. K., Morak-Młodawska, B., Saleem Qazi, A., & In, L. L. A. (2024). Enhancing the solubility and potency of tetrahydrocurcumin as an anti-cancer agent using a β-cyclodextrin inclusion complex approach. PLOS ONE. https://doi.org/10.1371/journal.pone.0305171
Vancouver
Low ZX, Teo MYM, Juliana Nordin F, Palanirajan VK, Morak-Młodawska B, Saleem Qazi A, et al. Enhancing the solubility and potency of tetrahydrocurcumin as an anti-cancer agent using a β-cyclodextrin inclusion complex approach. PLOS ONE. 2024. doi:10.1371/journal.pone.0305171
BibTeX
@article{Low2024,
author = {Low, Zhi Xuan and Teo, Michelle Yee Mun and Juliana Nordin, Fariza and Palanirajan, Vijayaraj Kumar and Morak-Młodawska, Beata and Saleem Qazi, Asma and In, Lionel Lian Aun},
title = {Enhancing the solubility and potency of tetrahydrocurcumin as an anti-cancer agent using a β-cyclodextrin inclusion complex approach},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0305171}
}
EUVIMED